The Journal of the Pharmacy Society of Wisconsin
  • Home
  • Past Issues
    • Journal Archives
    • JPSW 2023
    • JPSW 2022
    • JPSW 2021
    • JPSW 2020
    • JPSW 2019
    • JPSW 2018
    • JPSW 2017
  • JPSW Supplements
  • For Authors and Reviewers
    • Author Guidelines
    • CE Author Guidelines
    • Case Report Author Guidelines
    • Types of Manuscripts
    • Peer Review Information
    • Emerging Writers Course
    • Editorial Plans
    • Submit a Manuscript
  • Open-Access Series
    • Preceptor Development Series
    • Statistics Review Series
  • About
    • Advertise in The Journal
    • Editorial Advisory Committee
  • Contact

Attainment of Area Under the Curve Targets and Incidence of Nephrotoxicity Utilizing Local Pharmacokinetic Vancomycin Dosing Guidelines

by Alanna Ambrosius, PharmD, Kent Cook, PharmD, Jim Davis, RPh, Justin Guthman, PharmD

"Objective: Current vancomycin monitoring guidelines recognize area under the curve (AUC) to minimum inhibitory concentration (MIC) ratio as the target efficacy parameter for vancomycin. Despite the historical use of trough-only dosing as a surrogate marker for the AUC/MIC ratio, recent studies have challenged this strategy’s efficacy and safety. The objective of this study is to determine the extent to which vancomycin dosing and monitoring achieves target AUC levels and avoids nephrotoxicity. Secondary outcomes include incidence of clinical failure.
Methods: While receiving vancomycin therapy, adult patients were dosed and monitored according to current practice, with one additional vancomycin concentration drawn per dose-adjustment period to calculate the AUC. For the primary outcomes, percent of AUC levels within the established goal range of 400-600 mg h/L was calculated. Percent of patients who developed nephrotoxicity within 21 days of vancomycin initiation, or until the termination of their inpatient stay, was calculated. For the secondary outcomes, escalation to other methicillin-resistant Staphylococcus aureus active agents was measured.

Results: Of 46 AUC values calculated, 39.1% of values were in the target range of 400-600 mg h/L. There were notable variations between trough levels obtained and the calculated AUC. Of 43 patients, 16.3% developed nephrotoxicity. When limited to nephrotoxicity likely attributable to vancomycin, the incidence was lower at 6.98%. One patient required escalation of therapy to an alternate agent.
Conclusion: Trough levels obtained during this study did not accurately predict AUC values calculated, and incidence of nephrotoxicity was confounded by concomitant nephrotoxic agents.”

Keywords: Humans, Adult, Vancomycin, Methicillin-Resistant Staphylococcus aureus, Area Under Curve, Methicillin, Incidence, Goals, Inpatients, Microbial Sensitivity Tests, Renal Insufficiency, Biomarkers

Download PDF 

2020 November/December Table of Contents 

The Journal of the Pharmacy Society of Wisconsin


Past Issues

2020
2021
​2022
2019
2018
2017

About PSW

www.pswi.org

Contact Us

thejournal@pswi.org
  • Home
  • Past Issues
    • Journal Archives
    • JPSW 2023
    • JPSW 2022
    • JPSW 2021
    • JPSW 2020
    • JPSW 2019
    • JPSW 2018
    • JPSW 2017
  • JPSW Supplements
  • For Authors and Reviewers
    • Author Guidelines
    • CE Author Guidelines
    • Case Report Author Guidelines
    • Types of Manuscripts
    • Peer Review Information
    • Emerging Writers Course
    • Editorial Plans
    • Submit a Manuscript
  • Open-Access Series
    • Preceptor Development Series
    • Statistics Review Series
  • About
    • Advertise in The Journal
    • Editorial Advisory Committee
  • Contact